Multicentric real world evidence with palbociclib in hormone positive HER2 negative metastatic breast cancer in Indian population

Multicentric real world evidence with palbociclib in hormone positive HER2 negative metastatic breast cancer in Indian population

Abstract The combination of cyclin dependent kinase 4/6 inhibitors with endocrine therapy is the standard therapy in hormone receptor positive HER-2 negative metastatic breast cancer (HR+/HER2− MBC). Several randomized trials have shown the benefits of this combination, however, real world evidence...

Full description

Saved in:
Bibliographic Details
Main Authors: Chaturbhuj Agrawal, Pankaj Goyal, Amit Agarwal, Rupal Tripathi, Chandragouda Dodagoudar, Saphalta Baghmar, Archana Sharma, Ullas Batra, Vineet Talwar, Sumit Goyal, Rajeev Kumar, Dinesh Chandra Doval
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
Medicine
R
Science
Q
Online Access:https://doaj.org/article/0a2eee6afaf34fa489c4e65d644828a3
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/0a2eee6afaf34fa489c4e65d644828a3

Similar Items